跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 源峰
教授
,
臨床醫學研究所
合聘教授
,
國際醫學研究碩博士學位學程
https://orcid.org/0000-0003-4456-0766
電子郵件
d001089012
tmu.edu
tw
h-index
1470
引文
22
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2001
2024
每年研究成果
概覽
指紋
網路
專案
(16)
研究成果
(67)
資料集
(6)
類似的個人檔案
(6)
指紋
查看啟用 Yuan-Feng Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
down Regulation
97%
Upregulation
77%
Autophagy
59%
Radiosensitivity
49%
Chaperonin
47%
Tubulin
35%
Guanylate-Binding Protein
35%
Catenin
35%
Cell Migration
30%
Cell Death
29%
Survival Rate
27%
Protein Catabolism
27%
Gene Set Enrichment Analysis
26%
Mesenchymal-Epithelial Transition
25%
Drive
23%
Monocyte
23%
RUNX2
23%
CD14
23%
Synapsin I
23%
Phospholipase C
23%
Phosphoserine
23%
Transaminase
23%
Mitogen-Activated Protein Kinase
23%
Computer Model
22%
Aldolase A
22%
MMP9
21%
Gelatinase B
21%
Luciferase
20%
E2F
20%
Messenger RNA
19%
Protein-Protein Interaction
19%
IC50
18%
Reverse Transcription Polymerase Chain Reaction
17%
Tumor Necrosis Factor
17%
Caspase
17%
Drug Resistance
16%
Microarrays
16%
Mammalian Target of Rapamycin
16%
Immune Checkpoints
16%
STAT1
15%
Overall Survival
15%
Gene Expression Profiling
15%
Macrophage
14%
Metabolic Pathway
14%
Dendritic Cell
13%
Cell Proliferation
13%
Progression Free Survival
13%
IDH1
13%
Autophagosome
13%
Medicine and Dentistry
Metastatic Carcinoma
95%
Lung Cancer
82%
Cancer Cell
51%
down Regulation
41%
Malignant Neoplasm
39%
Programmed Cell Death
36%
Clear Cell Renal Cell Carcinoma
35%
Colorectal Cancer
35%
Upregulation
34%
Head and Neck Squamous Cell Carcinoma
32%
Mouth Squamous Cell Carcinoma
28%
Diabetes Mellitus
25%
Non Small Cell Lung Cancer
25%
Oral Cancer
23%
Nodular Melanoma
23%
Fructose Bisphosphate Aldolase
22%
Biological Marker
21%
Gelatinase B
21%
Glioblastoma
20%
Cancer Growth
19%
Maturity Onset Diabetes of the Young
19%
Radiosensitivity
18%
Snail
16%
Squamous Cell Carcinoma Cell
16%
Prognostic Factor
16%
Protein-Protein Interaction
16%
Lymph Node Metastasis
16%
Head and Neck Cancer
15%
In Vitro
14%
Guanine Nucleotide Binding Protein
14%
Liver Cancer
14%
Ovarian Cancer
14%
Lung Adenocarcinoma
13%
Synapsin I
13%
Cohort Analysis
13%
Autophagy
13%
Drive
11%
Follistatin
11%
Atherosclerosis
11%
Cell Growth
11%
Pervasive Developmental Disorder
11%
microRNA
11%
Activin A
11%
Growth Inhibition
11%
Triple Negative Breast Cancer
11%
Microfold Cell
11%
Glucose Transporter 4
11%
Sarcopenia
11%
Paclitaxel
11%
Programmed Death 1 Ligand 1
11%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
87%
Metastasis
56%
Triple Negative Breast Cancer
47%
Renal Cell Carcinoma
47%
Paclitaxel
44%
Malignant Neoplasm
39%
Calcium Ion
38%
Phospholipase C
35%
Chemotherapy
32%
Mouth Squamous Cell Carcinoma
27%
Non Small Cell Lung Cancer
25%
Gelatinase B
23%
Follitropin
23%
Colorectal Cancer
23%
Mouth Cancer
23%
Lactoferrin
23%
Fructose Bisphosphate Aldolase
22%
Biological Marker
20%
Neoplasm
19%
Inducible Nitric Oxide Synthase
18%
Synapsin I
16%
Cancer Growth
16%
Caspase 3
15%
Mitogen Activated Protein Kinase P38
15%
Lymph Node Metastasis
15%
Guanine Nucleotide Binding Protein
14%
microRNA
14%
Breast Cancer
13%
Lung Adenocarcinoma
13%
Inositol
11%
Docetaxel
11%
Castration Resistant Prostate Cancer
11%
Cohort Study
11%
Resveratrol
11%
Chloroquine
11%
Adenylate Kinase
11%
Chronic Kidney Failure
11%
Polypeptide
11%
X Linked Inhibitor of Apoptosis
11%
Glycoprotein
11%
Tumor Necrosis Factor Receptor 1
11%
Tubulin
11%
Ovary Cancer
11%
Proteinase
11%
DNA Polymerase
11%
Programmed Cell Death
11%
Diabetes Mellitus
11%
Programmed Death 1 Ligand 1
11%
Fas Ligand
11%
Head and Neck Squamous Cell Carcinoma
11%
